242 related articles for article (PubMed ID: 12707721)
1. Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation.
Reimer P; Rüdiger T; Müller J; Rose C; Wilhelm M; Weissinger F
Ann Hematol; 2003 May; 82(5):305-9. PubMed ID: 12707721
[TBL] [Abstract][Full Text] [Related]
2. Effective high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation in a patient with the aggressive form of cytophagic histiocytic panniculitis.
Koizumi K; Sawada K; Nishio M; Katagiri E; Fukae J; Fukada Y; Tarumi T; Notoya A; Shimizu T; Abe R; Kobayashi H; Koike T
Bone Marrow Transplant; 1997 Jul; 20(2):171-3. PubMed ID: 9244423
[TBL] [Abstract][Full Text] [Related]
3. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
[No Abstract] [Full Text] [Related]
4. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation.
Nawa Y; Takenaka K; Shinagawa K; Deguchi S; Matsumura N; Koyama S; Hiramatsu Y; Omoto E; Yoshino T; Harada M
Bone Marrow Transplant; 1999 Jun; 23(12):1321-2. PubMed ID: 10414923
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous panniculitis-like T-cell lymphoma in a child with trisomy 21.
Mixon B; Drach L; Monforte H; Barbosa J
Fetal Pediatr Pathol; 2010; 29(6):380-4. PubMed ID: 21043561
[TBL] [Abstract][Full Text] [Related]
6. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the therapeutic effects of high-dose chemotherapy and autologous stem cell transplantation in T cell lymphoma].
Wang Y; Wu DP; Wu XJ
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):298-9. PubMed ID: 20510084
[No Abstract] [Full Text] [Related]
8. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
[No Abstract] [Full Text] [Related]
9. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
[TBL] [Abstract][Full Text] [Related]
10. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
[No Abstract] [Full Text] [Related]
11. Update in T-cell lymphoma.
O'Connor OA
Clin Adv Hematol Oncol; 2010 Sep; 8(9):604-6. PubMed ID: 21157409
[No Abstract] [Full Text] [Related]
12. Primary mediastinal large B-cell lymphoma.
Ergul SM; Lal A; Afri L; Frei-Lahr D
South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
Vranovsky A; Ladicka M; Lakota J
Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043
[TBL] [Abstract][Full Text] [Related]
14. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma.
Rodriguez VR; Joshi A; Peng F; Rabah RM; Stockmann PT; Savaşan S
Pediatr Blood Cancer; 2009 Mar; 52(3):406-8. PubMed ID: 18985722
[TBL] [Abstract][Full Text] [Related]
16. B cell lymphoma-associated hemophagocytic syndrome after PBSCT.
Takahashi T; Kanda Y; Mori M; Saito T; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Mar; 21(6):623-5. PubMed ID: 9543068
[TBL] [Abstract][Full Text] [Related]
17. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
Mounier N; Gisselbrecht C; Brière J; Haioun C; Feugier P; Offner F; Recher C; Stamatoullas A; Morschhauser F; Macro M; Thieblemont C; Sonet A; Fabiani B; Reyes F;
J Clin Oncol; 2004 Jul; 22(14):2826-34. PubMed ID: 15254050
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Kouzaki H; Kitanishi T; Kitano H; Suzuki M
Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
[TBL] [Abstract][Full Text] [Related]
20. Thoracic subcutaneous infiltration: an unusual presentation of subcutaneous panniculitis-like T-cell lymphoma.
Ballanger F; Barbarot S; Le Gouill S; Gaillard F; Cassagnau E; Lodé L; Dréno B; Stalder JF
Acta Derm Venereol; 2009; 89(4):427-9. PubMed ID: 19688166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
